Participating Faculty: Strategies for Improving Outcomes in the Management of Epilepsy: Clinician and Payer Perspectives - Part II

Supplements and Featured Publications, Strategies for Improving Outcomes in the Management of Epilepsy: Clinician and Payer Perspectives - , Volume 17, Issue 7 Suppl

Strategies for Improving Outcomes in the Management of Epilepsy: Clinician and Payer Perspectives - Part II

This supplement to The American Journal of Managed Care provides an overview of epilepsy, including definition, diagnosis, and classification. Also discussed are the available treatments for epilepsy, considerations when selecting therapy for individual patients, and the role of combination therapy.

Faculty

Michael Privitera, MD

Professor of Neurology

University of Cincinnati College of Medicine

Director

Epilepsy Center at the UC Neuroscience Institute

Cincinnati, Ohio

Faculty Disclosures

Michael Privitera, MD has disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Grants: UCB, Inc

Honoraria: Janssen-Cilag; Pfizer; UCB, Inc

Lectureship: Pfizer; UCB, Inc

This supplement was supported by UCB, Inc.

The contents of this supplement may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Publisher’s Note

The opinions expressed in this supplement are those of the authors, presenters, and/or panelists and are not attributable to the sponsor or the publisher, editor, or editorial board of The American Journal of Managed Care. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this supplement are not necessarily the same as indicated in the package insert for the product and may reflect the clinical experience of the authors, presenters, and/or panelists or may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Supplement Policy Statement

Standards for Supplements to The American Journal of Managed Care

All supplements to The American Journal of Managed Care are designed to facilitate and enhance ongoing medical education in various therapeutic disciplines. All Journal supplements adhere to standards of fairness and objectivity, as outlined below. Supplements to The American Journal of Managed Care will:

I. Be reviewed by at least one independent expert from a recognized academic medical institution.

II. Disclose the source of funding in at least one prominent place.

III. Be free from editorial control exerted by personnel from the funding organization.

IV. Disclose any existence of financial interests of supplement contributors to the funding organization.

V. Use generic drug names only, except as needed to differentiate between therapies of similar class and indication.

VI. Be up-to-date, reflecting the current (as of date of publication) standard of care.

VII. Be visually distinct from The American Journal of Managed Care.

VIII. Publish information that is substantially different in form and content from that of the accompanying edition of The American Journal of Managed Care.

IX. Prohibit excessive remuneration for contributors and reviewers.

X. Carry no advertising.